Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Revenue	$ 7,582	$ 4,285
Costs and expenses:
Cost of revenue (excluding depreciation and amortization)	3,414	1,036
Research and development	32,368	16,233
Sales and marketing	6,701	2,667
General and administrative	14,020	10,581
Depreciation and amortization	3,955	1,791
Total operating costs and expenses	60,458	32,308
Loss from operations	(52,876)	(28,023)
Gain (loss) on change in fair value of warrant liabilities	8,627	(3,610)
Interest income, net	4,799	4,231
Other income (expense), net	(134)	64
Loss before income tax expense	(39,584)	(27,338)
Income tax benefit (expense)	(8)	0
Net loss	$ (39,592)	$ (27,338)
Net loss per share attributable to common stockholders—basic	$ (0.19)	$ (0.14)
Net loss per share attributable to common stockholders—diluted	$ (0.19)	$ (0.14)
Weighted average shares used in computing net loss per share attributable to common stockholders—basic	208,159,439	200,112,855
Weighted average shares used in computing net loss per share attributable to common stockholders—diluted	208,159,439	200,112,855